Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy

Circulation: Cardiovascular Imaging

Volumn 7, Issue 1, 2014, Pages 11-19

  Urbano Moral, Jose Angel ^a   Rowin, Ethan J ^a   Maron, Martin S ^a   Crean, Andrew ^b   Pandian, Natesa G ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cardiomyopathy; Echocardiography; Hypertrophic; Magnetic resonance imaging

Indexed keywords

GADOLINIUM PENTETATE; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; THREE DIMENSIONAL ECHOCARDIOGRAPHY; THREE DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY; BIOMECHANICS; CHI SQUARE DISTRIBUTION; COMPUTER ASSISTED DIAGNOSIS; ECHOCARDIOGRAPHY; ECHOGRAPHY; FIBROSIS; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; STATISTICAL MODEL;

CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; MAGNETIC RESONANCE IMAGING;

ADULT; BIOMECHANICAL PHENOMENA; CARDIOMYOPATHY, HYPERTROPHIC; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84897020050     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.113.000842     Document Type: Article

References (33)

1. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381: 242-255.
2. Maron BJ, Seidman CE, Ackerman MJ, Towbin JA, Maron MS, Ommen SR, Nishimura RA, Gersh BJ. How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy. Circ Cardiovasc Genet. 2009;2: 81-85; discussion 86.
3. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54: 220-228.
4. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124: 2761-2796.
5. McLeod CJ, Bos JM, Theis JL, Edwards WD, Gersh BJ, Ommen SR, Ackerman MJ. Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations. Am Heart J. 2009;158: 799-805.
6. Pouleur H, Rousseau MF, van Eyll C, Brasseur LA, Charlier AA. Forcevelocity-length relations in hypertrophic cardiomyopathy: evidence of normal or depressed myocardial contractility. Am J Cardiol. 1983;52: 813-817.
7. Marian AM. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet. 2000;355: 58-60.
8. Kramer CM, Reichek N, Ferrari VA, Theobald T, Dawson J, Axel L. Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation. 1994;90: 186-194.
9. Ennis DB, Epstein FH, Kellman P, Fananapazir L, McVeigh ER, Arai AE. Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging. Magn Reson Med. 2003;50: 638-642.
10. Carasso S, Yang H, Woo A, Vannan MA, Jamorski M, Wigle ED, Rakowski H. Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr. 2008;21: 675-683.
11. Urbano Moral JA, Arias Godinez JA, Maron MS, Malik R, Eagan JE, Patel AR, Pandian NG. Left ventricular twist mechanics in hypertrophic cardiomyopathy assessed by three-dimensional speckle tracking echocardiography. Am J Cardiol. 2011;108: 1788-1795.
12. Popović ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M, Flamm SD, Thomas JD, Lever HM, Desai MY. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr. 2008;21: 1299-1305.
13. Yang H, Carasso S, Woo A, Jamorski M, Nikonova A, Wigle ED, Rakowski H. Hypertrophy pattern and regional myocardial mechanics are related in septal and apical hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2010;23: 1081-1089.
14. Olivotto I, Maron BJ, Appelbaum E, Harrigan CJ, Salton C, Gibson CM, Udelson JE, O'Donnell C, Lesser JR, Manning WJ, Maron MS. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2010;106: 261-267.
15. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41: 1561-1567.
16. Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson. 2012;14: 76.
17. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40: 2156-2164.
18. Aletras AH, Tilak GS, Hsu LY, Arai AE. Heterogeneity of intramural function in hypertrophic cardiomyopathy: mechanistic insights from MRI late gadolinium enhancement and high-resolution displacement encoding with stimulated echoes strain maps. Circ Cardiovasc Imaging. 2011;4: 425-434.
19. Picard MH, Adams D, Bierig SM, Dent JM, Douglas PS, Gillam LD, Keller AM, Malenka DJ, Masoudi FA, McCulloch M, Pellikka PA, Peters PJ, Stainback RF, Strachan GM, Zoghbi WA; American Society of Echocardiography. American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr. 2011;24: 1-10.
20. Jasaityte R, Heyde B, D'hooge J. Current state of three-dimensional myocardial strain estimation using echocardiography. J Am Soc Echocardiogr. 2013;26: 15-28.
21. Urbano-Moral JA, Arias-Godinez JA, Ahmad R, Malik R, Kiernan MS, Denofrio D, Pandian NG, Patel AR. Evaluation of myocardial mechanics with three-dimensional speckle tracking echocardiography in heart transplant recipients: comparison with two-dimensional speckle tracking and relationship with clinical variables. Eur Heart J Cardiovasc Imaging. 2013;14: 1167-1173.
22. Nesser HJ, Mor-Avi V, Gorissen W, Weinert L, Steringer-Mascherbauer R, Niel J, Sugeng L, Lang RM. Quantification of left ventricular volumes using three-dimensional echocardiographic speckle tracking: comparison with MRI. Eur Heart J. 2009;30: 1565-1573.
23. Moravsky G, Ofek E, Rakowski H, Butany J, Williams L, Ralph-Edwards A, Wintersperger BJ, Crean A. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. J AM COLL CARDIOL. Cardiovasc Imaging. 2013;6: 587-596.
24. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8: 135-160.
25. Young AA, Kramer CM, Ferrari VA, Axel L, Reichek N. Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy. Circulation. 1994;90: 854-867.
26. Kansal MM, Lester SJ, Surapaneni P, Sengupta PP, Appleton CP, Ommen SR, Ressler SW, Hurst RT. Usefulness of two-dimensional and speckle tracking echocardiography in "Gray Zone" left ventricular hypertrophy to differentiate professional football player's heart from hypertrophic cardiomyopathy. Am J Cardiol. 2011;108: 1322-1326.
27. Baccouche H, Maunz M, Beck T, Gaa E, Banzhaf M, Knayer U, Fogarassy P, Beyer M. Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography. Echocardiography. 2012;29: 668-677.
28. Garceau P, Carasso S, Woo A, Overgaard C, Schwartz L, Rakowski H. Evaluation of left ventricular relaxation and filling pressures in obstructive hypertrophic cardiomyopathy: comparison between invasive hemodynamics and two-dimensional speckle tracking. Echocardiography. 2012;29: 934-942.
29. Sengupta PP, Narula J. LV segmentation and mechanics in HCM: twisting the Rubik's Cube into perfection! J Am Coll Cardiol Imaging. 2012;5: 765-768.
30. Wang TT, Kwon HS, Dai G, Wang R, Mijailovich SM, Moss RL, So PT, Wedeen VJ, Gilbert RJ. Resolving myoarchitectural disarray in the mouse ventricular wall with diffusion spectrum magnetic resonance imaging. Ann Biomed Eng. 2010;38: 2841-2850.
31. Bansal M, Sengupta PP. Curr Cardiol Rep. 2013;15: 339-353.
32. Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012;14: 13.
33. Gayat E, Ahmad H, Weinert L, Lang RM, Mor-Avi V. Reproducibility and inter-vendor variability of left ventricular deformation measurements by three-dimensional speckle-Tracking echocardiography. J Am Soc Echocardiogr. 2011;24: 878-885.